SCOPUS 정보 검색 플랫폼

Volumn 144, Issue 17, 2000, Pages 811-812

Combinations of hypericum perforatum (St. John's wort) with other pharmaceuticals is risky;Combinaties van hypericum perforatum (Sint-Janskruid) met andere geneesmiddelen risicovol

(3) Baede Van Dijk, P A a Van Galen, E a Lekkerkerker, J F F a

a Reumatoloog (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; HOMEOPATHIC AGENT; INDINAVIR; ORAL CONTRACEPTIVE AGENT; PHENPROCOUMON; THEOPHYLLINE; WARFARIN;

ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; HUMAN; HYPERICUM PERFORATUM;

ANTICOAGULANTS; ANTIVIRAL AGENTS; CONTRACEPTIVES, ORAL; DRUG INTERACTIONS; ENZYME INHIBITORS; HERB-DRUG INTERACTIONS; HUMANS; HYPERICUM; PLANTS, MEDICINAL;

EID: 0034701576 PISSN: 00282162 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (21)

References (8)

1
- 0034639643
- Indinavir concentrations and St. John's wort
- Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St. John's wort. Lancet 2000;355:547-8.
- (2000) Lancet , vol.355 , pp. 547-548
- Piscitelli, S.C.¹ Burstein, A.H.² Chaitt, D.³ Alfaro, R.M.⁴ Falloon, J.⁵

2
- 0033547648
- Second thoughts about safety of St. John's wort
- Ernst E. Second thoughts about safety of St. John's wort. Lancet 1999;354:2014-6.
- (1999) Lancet , vol.354 , pp. 2014-2016
- Ernst, E.¹

3
- 0033604711
- De rol van cytochroom-P450-enzymen bij geneesmiddeleninteracties
- Baede-van Dijk PA, Graeff PA de, Lekkerkerker JFF. De rol van cytochroom-P450-enzymen bij geneesmiddeleninteracties. Ned Tijdschr Geneeskd 1999;143:2607-11.
- (1999) Ned Tijdschr Geneeskd , vol.143 , pp. 2607-2611
- Baede-Van Dijk, P.A.¹ De Graeff, P.A.² Lekkerkerker, J.F.F.³

4
- 0000006828
- Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum)
- Johne A, Brockmöller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999;66:338-45.
- (1999) Clin Pharmacol Ther , vol.66 , pp. 338-345
- Johne, A.¹ Brockmöller, J.² Bauer, S.³ Maurer, A.⁴ Langheinrich, M.⁵ Roots, I.⁶

5
- 0000203223
- Interaction of St. John's wort extract with phenprocoumon
- Maurer A, Johne A, Bauer S, Brockmöller J, Donath F, Roots I, et al. Interaction of St. John's wort extract with phenprocoumon. Eur J Clin Pharmacol 1999;55:A22.
- (1999) Eur J Clin Pharmacol , vol.55
- Maurer, A.¹ Johne, A.² Bauer, S.³ Brockmöller, J.⁴ Donath, F.⁵ Roots, I.⁶

6
- 0032914931
- Potential metabolic interaction between St. John's wort and theophylline
- Nebel A, Schneider BJ, Baker RK, Kroll DJ. Potential metabolic interaction between St. John's wort and theophylline [letter]. Ann Pharmacother 1999;33:502.
- (1999) Ann Pharmacother , vol.33 , pp. 502
- Nebel, A.¹ Schneider, B.J.² Baker, R.K.³ Kroll, D.J.⁴

7
- 0034639564
- Safety of St. John's wort
- Yue QY, Bergquist C, Gerden B. Safety of St. John's wort. Lancet 2000;355:576-7.
- (2000) Lancet , vol.355 , pp. 576-577
- Yue, Q.Y.¹ Bergquist, C.² Gerden, B.³

8
- 0000248189
- Urinary 6-β-hydroxycortisol excretion rate is affected by treatment with hypericum extract
- Kerb B, Bauer S, Brockmöller J, Roots I. Urinary 6-β-hydroxycortisol excretion rate is affected by treatment with hypericum extract. Eur J Clin Pharmacol 1997;52:A186.
- (1997) Eur J Clin Pharmacol , vol.52
- Kerb, B.¹ Bauer, S.² Brockmöller, J.³ Roots, I.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.